Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Medchemexpress LLC Lyn-1604 dihydrochloride | 2310109-38-5 | 99.6% | 657.54 | C33H45Cl4N3O2 | 100 MG
SDP

Catalog No. 5000248227
Encompass_Preferred

LYN-1604 dihydrochloride is a research-grade small molecule activator of UNC-51-like kinase 1 (ULK1), used to study autophagy and cell death pathways in preclinical models such as triple negative breast cancer. The compound is supplied as the dihydrochloride salt and is provided with analytical documentation for research use.

  • Potent ULK1 activator (EC50 = 18.94 nM).
  • High purity suitable for research applications.
  • Available as solid and as a DMSO solution for convenient dosing.
  • Analytical documentation available, including COA, HNMR, and LCMS.
  • Supplied as the dihydrochloride salt for consistent formulation.

Catalog No. 50-002-48227 Supplier Medchemexpress LLC Supplier No. HY101923B100MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

LYN-1604 dihydrochloride is a research-grade small molecule activator of UNC-51-like kinase 1 (ULK1), used to study autophagy and cell death pathways in preclinical models such as triple negative breast cancer. The compound is supplied as the dihydrochloride salt and is provided with analytical documentation for research use.

  • Potent ULK1 activator (EC50 = 18.94 nM).
  • High purity suitable for research applications.
  • Available as solid and as a DMSO solution for convenient dosing.
  • Analytical documentation available, including COA, HNMR, and LCMS.
  • Supplied as the dihydrochloride salt for consistent formulation.

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.